Kurin Lock is used for collecting blood samples for blood culture.The innovative aspects are that the technology diverts and isolates the first flash (about 0.15 ml) of blood, which may contain contaminants that can lead to a false-positive blood culture result. The intended place in therapy would be when samples for blood culture are needed, as an alternative to standard collection methods.
 
Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process MTEP
ID number 582

Provisional Schedule

Resolution 27 February 2024
Expected publication 27 March 2024

Project Team

Project lead Aamer Jawed

Email enquiries

Stakeholders

External assessment group Cedar
Manufacturers Iskus Health
Patient carer organisations The ITP Support Association
External Assessment Group Cedar Health Technology Research Centre

Timeline

Key events during the development of the guidance:

Date Update
08 December 2023 Committee meeting: 2
17 October 2023 - 13 November 2023 Draft guidance: 1
22 September 2023 Committee meeting: 1
02 December 2022 Scope published
26 October 2022 Stakeholder registration opens
21 September 2022 In progress. In progress
04 July 2022 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual